Dalton Medicinal Chemistry Partners and Boehringer Ingelheim (Canada) Ltd. enter into a Medicinal Chemistry Agreement
27-Mar-2007
Dalton Medicinal Chemistry Partners will utilize their medicinal chemistry expertise to design and synthesize novel compounds against a number of antiviral targets selected by Boehringer Ingelheim (Canada) Ltd.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.